MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$335M
1-Year Return
7.01%
This Quarter Return
-3.18%
1 Year Return
+7.01%
3 Year Return
+65.15%
5 Year Return
+135.64%
10 Year Return
+335.37%
AUM
$2.8B
AUM Growth
-$4.56B
(-62%)
Cap. Flow
-$4.16B
Cap. Flow
% of AUM
-148.28%
Top 10 Holdings %
Top 10 Hldgs %
26.34%
Holding
2,829
New
47
Increased
16
Reduced
2,170
Closed
587
Top Buys
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$15.8M |
| 2 |
Constellation Energy
CEG
|
+$1.13M |
| 3 |
Sea Limited
SE
|
+$1.05M |
| 4 |
AerCap
AER
|
+$347K |
| 5 |
Phillips Edison & Co
PECO
|
+$242K |
Top Sells
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$231M |
| 3 |
Amazon
AMZN
|
+$140M |
| 4 |
Tesla
TSLA
|
+$85.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$77.6M |
Sector Composition
| 1 | Technology | 22.41% |
| 2 | Healthcare | 12.39% |
| 3 | Financials | 12.03% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Heritage Commerce
HTBK
$624M
| $41.5K | ﹤0.01% |
3,692
-11,345
| -75% | -$128K |
|
1702
Movado Group
MOV
$438M
| $41.5K | ﹤0.01% |
1,063
-3,146
| -75% | -$123K |
|
1703
United Fire Group
UFCS
$807M
| $41.5K | ﹤0.01% |
1,336
-3,594
| -73% | -$112K |
|
1704
Portillo's
PTLO
$441M
| $41.5K | ﹤0.01% |
1,689
-5,017
| -75% | -$123K |
|
|
VXRT
1705
DELISTED
Vaxart
VXRT
| $41.4K | ﹤0.01% |
8,214
-17,604
| -68% | -$88.7K |
|
|
ACRE
1706
Ares Commercial Real Estate
ACRE
$266M
| $41.3K | ﹤0.01% |
2,662
-7,805
| -75% | -$121K |
|
1707
York Water
YORW
$445M
| $41.1K | ﹤0.01% |
915
-2,334
| -72% | -$105K |
|
1708
Grid Dynamics Holdings
GDYN
$642M
| $41.1K | ﹤0.01% |
2,920
-8,370
| -74% | -$118K |
|
1709
Life Time Group Holdings
LTH
$6.29B
| $41.1K | ﹤0.01% |
2,825
-8,389
| -75% | -$122K |
|
1710
Rocket Pharmaceuticals
RCKT
$341M
| $41K | ﹤0.01% |
2,584
-8,301
| -76% | -$132K |
|
1711
Instil Bio
TIL
$163M
| $40.9K | ﹤0.01% |
190
-566
| -75% | -$122K |
|
1712
Avidity Biosciences
RNA
$5.76B
| $40.8K | ﹤0.01% |
2,208
-7,161
| -76% | -$132K |
|
1713
Gannett
GCI
$620M
| $40.7K | ﹤0.01% |
9,025
-18,898
| -68% | -$85.2K |
|
1714
Vanda Pharmaceuticals
VNDA
$266M
| $40.6K | ﹤0.01% |
3,588
-11,217
| -76% | -$127K |
|
1715
Allogene Therapeutics
ALLO
$251M
| $40.4K | ﹤0.01% |
4,433
-13,481
| -75% | -$123K |
|
1716
First Mid Bancshares
FMBH
$945M
| $40.3K | ﹤0.01% |
1,047
-3,387
| -76% | -$130K |
|
1717
Globalstar
GSAT
$3.79B
| $40.3K | ﹤0.01% |
1,827
-8,563
| -82% | -$189K |
|
1718
Byline Bancorp
BY
$1.33B
| $40.3K | ﹤0.01% |
1,509
-4,730
| -76% | -$126K |
|
|
HIBB
1719
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $40.2K | ﹤0.01% |
907
-3,181
| -78% | -$141K |
|
1720
Kezar Life Sciences
KZR
$28.9M
| $40.1K | ﹤0.01% |
241
-721
| -75% | -$120K |
|
1721
Mitek Systems
MITK
$467M
| $40K | ﹤0.01% |
2,729
-8,410
| -76% | -$123K |
|
1722
Crescent Energy
CRGY
$2.21B
| $40K | ﹤0.01% |
2,307
-6,371
| -73% | -$110K |
|
1723
Ocugen
OCGN
$334M
| $40K | ﹤0.01% |
12,120
-36,758
| -75% | -$121K |
|
1724
PMV Pharmaceuticals
PMVP
$65.2M
| $39.9K | ﹤0.01% |
1,917
-6,207
| -76% | -$129K |
|
1725
Koppers
KOP
$567M
| $39.7K | ﹤0.01% |
1,441
-3,789
| -72% | -$104K |
|